Hubei Gedian humanwell Pharmaceutical is an API manufacturer based in China. It holds 19 active US drug master files across a filed portfolio of 19 molecules. Its filings concentrate with MINSA (CR) and DAV (Vietnam). Its GMP standing is certified by MFDS (Korea). Its most recent recorded inspection, by US FDA, closed on 7 November 2025 as OAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| China, China | 3004117486 |
| Molecule | Regulators | Docs |
|---|---|---|
| Progesterone | SFDA (Saudi Arabia), US FDA | 3 |
| Budesonide | SFDA (Saudi Arabia), US FDA | 2 |
| Dutasteride | US FDA | 2 |
| Finasteride | SFDA (Saudi Arabia), US FDA | 2 |
| Apalutamide | US FDA | 1 |
| Clascoterone | US FDA | 1 |
| Cyproterone | SFDA (Saudi Arabia) | 1 |
| Desonide | US FDA | 1 |
| Dienogest | US FDA | 1 |
| Drospirenone | US FDA | 1 |
| Eslicarbazepine Acetate | US FDA | 1 |
| Estradiol | US FDA | 1 |
| Ganciclovir | SFDA (Saudi Arabia) | 1 |
| Lasmiditan | US FDA | 1 |
| Levonorgestrel | US FDA | 1 |
| Medroxyprogesterone Acetate | US FDA | 1 |
| Mirabegron | US FDA | 1 |
| Oxcarbazepine | US FDA | 1 |
| Valganciclovir | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 3 | None |
| DAV (Vietnam) | 1 | None |
| MFDS (Korea) | None | 4 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Hubei Gedian humanwell Pharmaceutical comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.